跳至主要内容
临床试验/NCT00168948
NCT00168948Unknown4 期

Intermittent Treatment With Sulfadoxine-Pyrimethamine for Malaria Control in Children: A Randomised, Double Blind, and Placebo-Controlled Clinical Trial

Charite University, Berlin, Germany0 个研究点目标入组 1,200 人开始时间: 2003年3月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
入组人数
1,200
主要终点
Efficacy and safety of IPTi with SP

研究概览

简要总结

- intermittent preventive treatment with SP in children to evaluate efficacy and safety of this drug combination in children in northern Ghana

详细描述

  • Sulfadoxine and pyrimethamine have long been used for malaria prevention and treatment. In this study, following suggestions of WHO, these drugs are used for intermittent treatment.
  • It will be tested if this approach reduces the number of malaria attacks and ameliorates the severity of the disease
  • It will also be determined if anemia due to malaria, which is prevalent in northern Ghana, may be reduced
  • Moreover, the interaction between red cell polymorphisms such as HbS, HbC, alpha-thalassemia and glucose-6-phosphate dehydrogenase deficiency and SP will be examined

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double

入排标准

年龄范围
2 Months 至 4 Months(Child)
性别
All
接受健康志愿者

入选标准

  • informed consent by parents or guardian
  • no concomitant serious disease
  • age >2 months

排除标准

  • serious allergy or hypersensitivity to sulfonamides or pyrimethamine
  • no severe hepatic or renal dysfunction
  • serious breach of study protocol

结局指标

主要结局

Efficacy and safety of IPTi with SP

Impact of IPTi on incidence on malaria attacks

Impact of IPTi on anemia

次要结局

  • Interaction between erythrocyte polymorphisms and SP
  • Influence on parasite multiplicity
  • Impact on child development

研究者

申办方类型
Other

相似试验